Experimental and Characterization Data
Other reagents and solvents used were of analytical grade and purchased from Sigma-Aldrich, Alfa
Aesar, Apollo Scientific Ltd., Fluka, Fluorochem or Acros and used as received. Buffers and HPLC eluents were prepared with nanopure water (resistivity 18. (E)-(2-(((Benzylideneamino)oxy)methyl)phenyl)boronic acid (12) 10 (3.0 mg, 0.02 mmol, 1.0 eq.) and benzaldehyde (2.8 µL, 0.03 mmol, 1.5 eq.) were dissolved in MeOH (0.2 mL) and the solution was stirred at room temperature overnight. The solution was directly purified by preparative HPLC (t R = 20.1 min). Product containing fractions were lyophilized to yield the desired compound as white solid (1.0 mg, 3.9 µmol, 22%). 1 
(E)-(2-(1-((Benzyloxy)imino)ethyl)phenyl)boronic acid (14)
This compound was synthesized according to a published procedure. 1 White solid (56.0 mg, 0.20 mmol, 68%). Analytical data was in agreement with the reported data.
(E)-(2-(((Benzyloxy)imino)methyl)phenyl)boronic acid (7)
This compound was synthesized according to a published procedure. 1 Analytical data was in agreement with the reported data. 
2-Formyl-4-hydroxyphenylboronic acid pinacol ester (15)
This compound was synthesized according to a published procedure. 2 White solid (151.0 mg, 0.61 mmol, 49%). Analytical data was in agreement with the reported data.
2-Formyl-5-hydroxyphenylboronic acid pinacol ester (30)
Under an Ar atmosphere, 2-bromo-4-hydroxybenzaldehyde (250.0 mg, 1.24 mmol, 1.0 eq.), bis(pinacolato)diboron (410.6 mg, 1.62 mmol, 1.3 eq.), Pd(dppf)Cl 2 (91.0 mg, 0.12 mmol, 10 mol%) and KOAc (366.2 mg, 3.73 mmol, 3.0 eq.) were suspended in freshly distilled dioxane (5 mL 
2-Formyl-4-(propargyloxy)phenylboronic acid pinacol ester (31)
Under a N 2 atmosphere 15 (50.0 mg, 0.20 mmol, 1.0 eq.) and propargyl bromide (26.9 µL, 0.24 mmol, 1.3 eq., 80% solution in toluene) were dissolved in DMF (0.5 mL) and K 2 CO 3 (41.8 mg, 0.30 mmol, 1.5 eq.) was added. The mixture was stirred at room temperature for 21 h and then diluted with EtOAc (2 x 15 mL). The combined organic layers were washed with brine (10 mL), dried over Na 2 SO 4 and the solvent was removed in vacuo. The crude product was purified by flash chromatography (10:1 cyclohexane/EtOAc) to yield the desired product as white solid (37.0 mg, 0.13 mmol, 64%). TLC (10:1 cyclohexane/EtOAc, UV/KMnO 4 ) R f = 0.24. 1 
2-Formyl-5-methoxyphenylboronic acid pinacol ester (32)
Under a N 2 atmosphere 30 (70.0 mg, 0.28 mmol, 1.0 eq.) was dissolved in DMF (1.0 mL) and K 2 CO 3 (58.5 mg, 0.42 mmol, 1.5 eq.) was added. 
2-Bromo-5-(dimethylamino)phenylmethanol (33)
This compound was synthesized according to a published procedure. 4 White solid (162.0 mg, 0.70 mmol, 75%). Analytical data was in agreement with the reported data. 
2-Bromo-5-dimethylaminobenzaldehyde (34)
This compound was synthesized according to a published procedure. 4 Yellow solid (76.0 mg, 0.33 mmol, 77%). Analytical data was in agreement with the reported data.
2-Formyl-4-(dimethylamino)phenylboronic acid pinacol ester (28)
Under an Ar atmosphere, 34 (50.0 mg, 0.22 mmol, 1.0 eq.), bis(pinacolato)diboron (72.4 mg, 0.28 mmol, 1.3 eq.), Pd(dppf)Cl 2 (16.0 mg, 0.02 mmol, 10 mol%) and KOAc (64.5 mg, 0.66 mmol, 3.0 eq.) were suspended in freshly distilled dioxane (1.5 mL). The mixture was heated to reflux for 
2-Nitro-4-methoxyphenyhydrazine (35)
This compound was synthesized according to a published procedure. 6 Dark red solid (853.0 mg, 4.66 mmol, 16%). Analytical data was in agreement with the reported data. 
2-Hydroxyphenylhydrazine pTsOH salt (36)
This compound was synthesized according to a published procedure. 7 Colorless plates (4.39 g, 14.8 mmol, 54%). Analytical data was in agreement with the reported data.
General Procedure for the Synthesis of 4,3-Borazaroisoquinolines (BIQ)
Boronic acid aldehyde (1.0 eq.) and phenylhydrazine (1.4 eq.) were suspended in DMSO/H 2 O (1:4) and the suspension was stirred at room temperature for 2 h. The mixture was diluted with MeCN until a clear solution was obtained. The product was purified by preparative HPLC (0.1% TFA) and the fractions were lyophilized.
2-Phenylbenzo[d][1,2,3]diazaborinin-1(2H)-ol (4)
4 was synthesized according to the general procedure. 2-Formylphenylboronic acid (2-FPBA) (5.0 mg, 0.03 mmol, 1.0 eq.) and phenylhydrazine (4.6 µL, 0.05 mmol, 1.4 eq.) were mixed in the solvent (1 mL). The product was isolated as white solid (4.0 mg, 0.02 mmol, 54%). Preparative HPLC: t R = 20.5 min. Analytical data was in agreement with reported data. 8
4-Methyl-2-phenylbenzo[d][1,2,3]diazaborinin-1(2H)-ol (18)
18 was synthesized according to the general procedure. 2-Acetylphenylboronic acid (5.0 mg, 0.03 mmol, 1.0 eq.) and phenylhydrazine (4.2 µL, 0.04 mmol, 1.4 eq.) were mixed in the solvent (1 mL). The product was isolated as yellow solid (6.0 mg, 0.03 mmol, 83%). Preparative HPLC: t R = 21.8 min. 1 
2-Phenyl-6-(propargyloxy)benzo[d][1,2,3]diazaborinin-1(2H)-ol (19)
19 was synthesized according to the general procedure. 31 (5.0 mg, 0.02 mmol, 1.0 eq.) and phenylhydrazine (2.4 µL, 0.03 mmol, 1.4 eq.) were mixed in the solvent (0.25 mL). The product was isolated as white solid (4.0 mg, 0.01 mmol, 83%). Preparative HPLC: t R = 21.2 min. 1 
2-(4-Methoxy-2-nitrophenyl)benzo[d][1,2,3]diazaborinin-1(2H)-ol (21)
2-Formylphenylboronic acid (10.0 mg, 0.07 mmol, 1.0 eq.) and 35 (17.1 mg, 0.09 mmol, 1.4 eq.) were dissolved in H 2 O/DMSO (4:1, 1.0 mL). The suspension was acidified with HCl (0.1 mL, 1N) and stirred for 67 h at 70°C. The mixture was directly purified by preparative HPLC (0.1% TFA, t R = 19.9 min) to yield the desired product as brown solid (12.0 mg, 0.04 mmol, 61%). 1 
Benzo[d]benzo[4,5][1,3,2]oxazaborolo[3,2-b][1,2,3]diazaborinin-3-ol (23)
23 was synthesized according to the general procedure. 15 (15.0 mg, 0.06 mmol, 1.0 eq.) and 36 (25.1 mg, 0.08 mmol, 1.4 eq.) were mixed in the solvent (1.0 mL). The product was isolated as white solid (13.0 mg, 0.06 mmol, 91%). Preparative HPLC: t R = 21.0 min. 1 
Benzo[d]benzo[4,5][1,3,2]oxazaborolo[3,2-b][1,2,3]diazaborinin-3-ol (24)
24 was synthesized according to the general procedure. 30 (15.0 mg, 0.06 mmol, 1.0 eq.) and 36 (25.1 mg, 0.08 mmol, 1.4 eq.) were mixed in the solvent (1.0 mL). The product was isolated as white solid (13.0 mg, 0.06 mmol, 91%). Preparative HPLC: t R = 20.5 min. 1 
Reversibility of Ketoximes

BIQ Formation
UV Studies on BIQ formation
General Information
All measurements were conducted on a Shimadzu UV-1800 UV-Vis spectrophotometer (190-1100 nm, bandwidth 1 nm) using 10 x 10 mm quartz cuvettes from Hellma Analytics (3500 µL).
Human Serum (HS) type AB (male) and reduced L-glutathione (GSH) were purchased from Sigma-Aldrich. Cuvettes were rinsed with deionized H 2 O followed by technical EtOH and dried under a N 2 stream prior to use. For all UV measurements the boronic acid was dissolved in the solvent and measured for 10 s. The hydrazine stock solution (freshly prepared, could not be used for longer than 1 h) was directly added into the cuvette, gently shaken three times and the measurement was continued. Formation of the hydrazone and BIQ were recorded in triplicate at 340 nm. The absorbance was measured every 0.5 s over a period of about 1500 s. The recorded data was analyzed with MS Excel. Hydrazone formation was too fast to determine exact rate constants by the described method.
The intramolecular BIQ formation showed first order behavior and was measured by the signal decrease at 340 nm (only hydrazone visible). Extinction coefficients for the hydrazone intermediate at 340 nm were determined by addition of 1.5 equivalents of the corresponding hydrazine to a known concentration of aldehyde (typically 10 µM), assuming that the highest absorbance is equal to complete conversion to the hydrazone (Lambert-Beer law). 
pH Effects on BIQ formation
Effects of Glutathione and Human Serum on BIQ formation
Stock solutions: 2490 µL of 15 stock solution was measured for 10 s, after which 15 µL (1.5 eq.) of the phenylhydrazine stock solution was added and measured. After 3.5 min 30 µL (3 eq.) of the hydroxylamine stock solution was added. BIQ formation showed to be much slower compared to previous results even though a ten times higher concentration was used ( Figure S10 ). This showed the decelerating effect of higher organic solvent concentrations. The results were analyzed and processed by MS Excel. After 13 h the mixture was analyzed by UPLC-MS (3% -25% (3 min) -95% (3.5 min) -95% (0.5 min) (B)). About 15% of the corresponding oxime product were observed, proving that the BIQ formation was faster than the hydrazone hydrolysis. 
Fluorescence Measurements
General Information
UV-Vis measurements were conducted on a Shimadzu UV-1800 UV-Vis spectrophotometer (190-1100 nm, bandwidth 1 nm) using 10 x 10 mm quartz cuvettes from Hellma Analytics (3500 µL).
Fluorescence emission measurements were performed on a Shimaduzu RF-5301PC spectrofluorophotometer with 3 nm spectral bandwidth. Quantum yield measurements were done on a Hamamatsu Quantaurus-QY Absolute PL quantum yields measurement system C11347-11 with an integrating sphere. All samples were prepared as 10 µM samples in DMSO. UV and fluorescence files were processed by MS Excel. 
UV-Vis/Fluorescence Spectra
Quantum Yield Determination
Quantum yields were determined at 10 µM concentration in DMSO with excitation wavelengths 370 nm and 365 nm for 28 and 27 respectively. 
